Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1254334A discloses novel terephthalamide derivatives inhibiting HBV and HIV. Discover scalable synthesis routes and cost-effective manufacturing strategies for high-purity antiviral intermediates.
Patent CN115974717A reveals a cost-effective synthesis for heptafluoroisopropyl bisamides. Discover high-yield routes for reliable agrochemical intermediate supply.
Patent CN105859549A reveals a novel oxidation chlorination route for high-purity agrochemical intermediate manufacturing with substantial cost reduction and supply chain reliability.
Patent CN111005033A reveals a green electroreduction route for sildenafil intermediates, eliminating heavy metals and toxic reducers for cost-effective API production.
Patent CN1409702A details a cost-effective asymmetric synthesis of Casodex enantiomers using citramalic acid, offering supply chain advantages over proline-based methods.
Patent CN108314646B reveals a novel Pd/Ni-MOF catalyst for Apalutamide intermediates, offering high purity, recyclability, and significant cost reduction in API manufacturing.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.
Novel patent CN120698982A details green synthesis of diamide insecticide intermediates offering cost reduction and supply chain reliability for global agrochemical manufacturing.
Patent CN107235852A reveals base-free amide synthesis using iridium catalysts. This method offers green chemistry benefits and cost reduction in pharmaceutical intermediate manufacturing supply chains.
Patent CN103387494A reveals a novel amine-mediated demethylation route for 2-hydroxy-4,5-dimethoxybenzoic acid, offering significant cost reduction and safer manufacturing for Acotiamide intermediates.
Patent CN106478725A reveals advanced recrystallization for TAF intermediates. Ensures over 99.5 percent optical purity and scalable manufacturing for global supply chains.
Patent CN101928229A reveals a cost-effective route for L-2-aminobutanamide hydrochloride, offering high purity and scalable manufacturing for global API supply chains.
Patent CN1805920A details a scalable route for HCV protease inhibitor intermediates using TEMPO oxidation and mild hydration, ensuring high purity and supply chain reliability.
Discover the asymmetric transformation method for L-2-aminobutanamide hydrochloride. Enhance purity and reduce costs in levetiracetam manufacturing with our advanced synthesis route.
Patent CN1095830C details a novel amine exchange method for producing fungicide intermediates, offering improved safety and industrial scalability for agrochemical manufacturers.
Novel 3-step route for Rivaroxaban intermediate reduces waste and cost. High purity API intermediate manufacturing via efficient isonitrification.
Patent CN113336665B reveals a metal-free route for arylamide synthesis using hypervalent iodine. This method offers mild conditions and high purity for pharmaceutical intermediates.
Advanced synthesis of MDL-100907 intermediate via PCl3 amidation. Reduces cost and improves yield for pharma supply chains.
Patent CN102020584A reveals a safer, cost-effective route for Levetiracetam intermediates using 2-bromobutyric acid, offering significant supply chain advantages.
Patent CN110078635B details a green amide synthesis using quaternary ammonium salts. Offers cost-effective ceramide production for cosmetics.